Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.

Shitara K, Muro K, Watanabe J, Yamazaki K, Ohori H, Shiozawa M, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Mori I, Yamanaka K, Hihara M, Soeda J, Misumi T, Yamamoto K, Yamashita R, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T.

Open source

DOI: 10.1038/s41591-023-02791-w
Published: 2024-02-12
Container: Nat Med
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-023-02791-w,
  title = {Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.},
  author = {Shitara K and  Muro K and  Watanabe J and  Yamazaki K and  Ohori H and  Shiozawa M and  Takashima A and  Yokota M and  Makiyama A and  Akazawa N and  Ojima H and  Yuasa Y and  Miwa K and  Yasui H and  Oki E and  Sato T and  Naitoh T and  Komatsu Y and  Kato T and  Mori I and  Yamanaka K and  Hihara M and  Soeda J and  Misumi T and  Yamamoto K and  Yamashita R and  Akagi K and  Ochiai A and  Uetake H and  Tsuchihara K and  Yoshino T.},
  year = {2024},
  journal = {Nat Med},
  doi = {10.1038/s41591-023-02791-w},
  url = {https://doi.org/10.1038/s41591-023-02791-w}
}

RIS

TY  - JOUR
TI  - Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
AU  - Shitara K
AU  -  Muro K
AU  -  Watanabe J
AU  -  Yamazaki K
AU  -  Ohori H
AU  -  Shiozawa M
AU  -  Takashima A
AU  -  Yokota M
AU  -  Makiyama A
AU  -  Akazawa N
AU  -  Ojima H
AU  -  Yuasa Y
AU  -  Miwa K
AU  -  Yasui H
AU  -  Oki E
AU  -  Sato T
AU  -  Naitoh T
AU  -  Komatsu Y
AU  -  Kato T
AU  -  Mori I
AU  -  Yamanaka K
AU  -  Hihara M
AU  -  Soeda J
AU  -  Misumi T
AU  -  Yamamoto K
AU  -  Yamashita R
AU  -  Akagi K
AU  -  Ochiai A
AU  -  Uetake H
AU  -  Tsuchihara K
AU  -  Yoshino T.
PY  - 2024
JO  - Nat Med
DO  - 10.1038/s41591-023-02791-w
UR  - https://doi.org/10.1038/s41591-023-02791-w
ER  -

APA

K, S., K, M., J, W., K, Y., H, O., M, S., A, T., M, Y., A, M., N, A., H, O., Y, Y., K, M., H, Y., E, O., T, S., T, N., Y, K., T, K., I, M., K, Y., M, H., J, S., T, M., K, Y., R, Y., K, A., A, O., H, U., K, T., & T., Y. (2024). Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.. Nat Med. https://doi.org/10.1038/s41591-023-02791-w

Source records

europe-pmc · retrieved 2026-09-27T02:06:45.647Z